Trials / Completed
CompletedNCT04486924
Performance and Safety of the Globe® Mapping and Ablation System With the GPS™ Module for the Treatment of Atrial Fibrillation
Evaluation of the Acute Performance and Safety of the Globe® Mapping and Ablation System With the GPS™ Module for the Treatment of Atrial Fibrillation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Kardium Inc. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the safety and acute performance of the Globe® Mapping and Ablation System with the GPS™ Module intended to conduct electroanatomic mapping and ablation treatment of subjects with atrial fibrillation (AF).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Globe Mapping and Ablation System | Prospective, non-randomized, open-label clinical study. |
Timeline
- Start date
- 2021-04-05
- Primary completion
- 2022-08-30
- Completion
- 2022-08-30
- First posted
- 2020-07-27
- Last updated
- 2023-02-10
Locations
2 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT04486924. Inclusion in this directory is not an endorsement.